{"id":"https://openalex.org/W4392153308","doi":"https://doi.org/10.1109/globecom54140.2023.10437710","title":"Microparticle-Based Controlled Drug Delivery Systems: From Experiments to Statistical Analysis and Design","display_name":"Microparticle-Based Controlled Drug Delivery Systems: From Experiments to Statistical Analysis and Design","publication_year":2023,"publication_date":"2023-12-04","ids":{"openalex":"https://openalex.org/W4392153308","doi":"https://doi.org/10.1109/globecom54140.2023.10437710"},"language":"en","primary_location":{"id":"doi:10.1109/globecom54140.2023.10437710","is_oa":false,"landing_page_url":"https://doi.org/10.1109/globecom54140.2023.10437710","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"GLOBECOM 2023 - 2023 IEEE Global Communications Conference","raw_type":"proceedings-article"},"type":"conference-paper","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035817861","display_name":"Sebastian Lotter","orcid":"https://orcid.org/0000-0002-1922-2733"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sebastian Lotter","raw_affiliation_strings":["Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058047812","display_name":"Tom Bellmann","orcid":"https://orcid.org/0000-0002-5914-9251"},"institutions":[{"id":"https://openalex.org/I4210147005","display_name":"FMP Technology (Germany)","ror":"https://ror.org/052z6qn75","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210147005"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tom Bellmann","raw_affiliation_strings":["FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","institution_ids":["https://openalex.org/I4210147005"]},{"raw_affiliation_string":"Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112914137","display_name":"Sophie Marx","orcid":null},"institutions":[{"id":"https://openalex.org/I4210147005","display_name":"FMP Technology (Germany)","ror":"https://ror.org/052z6qn75","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210147005"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sophie Marx","raw_affiliation_strings":["FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","institution_ids":["https://openalex.org/I4210147005"]},{"raw_affiliation_string":"Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091926316","display_name":"Mara Wesinger","orcid":null},"institutions":[{"id":"https://openalex.org/I4210147005","display_name":"FMP Technology (Germany)","ror":"https://ror.org/052z6qn75","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210147005"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Mara Wesinger","raw_affiliation_strings":["FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","institution_ids":["https://openalex.org/I4210147005"]},{"raw_affiliation_string":"Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018198060","display_name":"Lukas Brand","orcid":"https://orcid.org/0000-0001-7247-844X"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lukas Brand","raw_affiliation_strings":["Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074561882","display_name":"Maximilian Sch\u00e4fer","orcid":"https://orcid.org/0000-0002-3332-4701"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maximilian Sch\u00e4fer","raw_affiliation_strings":["Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034341324","display_name":"Dagmar Fischer","orcid":"https://orcid.org/0000-0002-9310-3441"},"institutions":[{"id":"https://openalex.org/I4210147005","display_name":"FMP Technology (Germany)","ror":"https://ror.org/052z6qn75","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210147005"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dagmar Fischer","raw_affiliation_strings":["FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FAU,Division of Pharmaceutical Technology and Biopharmacy,Erlangen,Germany","institution_ids":["https://openalex.org/I4210147005"]},{"raw_affiliation_string":"Division of Pharmaceutical Technology and Biopharmacy, FAU, Erlangen, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033990377","display_name":"Robert Schober","orcid":"https://orcid.org/0000-0002-6420-4884"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Schober","raw_affiliation_strings":["Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Digital Communications, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),Erlangen,Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1167","last_page":"1172"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13052","display_name":"Molecular Communication and Nanonetworks","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13052","display_name":"Molecular Communication and Nanonetworks","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10207","display_name":"Advanced biosensing and bioanalysis techniques","score":0.9969000220298767,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11407","display_name":"Innovative Microfluidic and Catalytic Techniques Innovation","score":0.9876000285148621,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microparticle","display_name":"Microparticle","score":0.8613743782043457},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"Drug delivery","score":0.6389201879501343},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.44976645708084106},{"id":"https://openalex.org/keywords/materials-science","display_name":"Materials science","score":0.22631555795669556},{"id":"https://openalex.org/keywords/nanotechnology","display_name":"Nanotechnology","score":0.18857020139694214},{"id":"https://openalex.org/keywords/engineering","display_name":"Engineering","score":0.17842066287994385},{"id":"https://openalex.org/keywords/chemical-engineering","display_name":"Chemical engineering","score":0.1461104154586792}],"concepts":[{"id":"https://openalex.org/C2777521759","wikidata":"https://www.wikidata.org/wiki/Q61186","display_name":"Microparticle","level":2,"score":0.8613743782043457},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6389201879501343},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.44976645708084106},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.22631555795669556},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.18857020139694214},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.17842066287994385},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.1461104154586792}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1109/globecom54140.2023.10437710","is_oa":false,"landing_page_url":"https://doi.org/10.1109/globecom54140.2023.10437710","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"GLOBECOM 2023 - 2023 IEEE Global Communications Conference","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.46000000834465027,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W5908806","https://openalex.org/W1211659131","https://openalex.org/W1964903133","https://openalex.org/W1979512544","https://openalex.org/W2009841111","https://openalex.org/W2015185493","https://openalex.org/W2169061810","https://openalex.org/W2321998191","https://openalex.org/W2330801783","https://openalex.org/W2614985500","https://openalex.org/W2746783668","https://openalex.org/W3008673236","https://openalex.org/W3010209426","https://openalex.org/W3048062595","https://openalex.org/W3101828722","https://openalex.org/W3127575390","https://openalex.org/W3171121036","https://openalex.org/W3178306758","https://openalex.org/W4234338799","https://openalex.org/W4248681815","https://openalex.org/W4319599108","https://openalex.org/W4392153308"],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W2056698985","https://openalex.org/W2184487690","https://openalex.org/W2525619074","https://openalex.org/W1664986234","https://openalex.org/W2160230796","https://openalex.org/W2366076914","https://openalex.org/W3179091597"],"abstract_inverted_index":{"Controlled":[0],"drug":[1,25,160,170],"delivery":[2,8],"(CDD),":[3],"the":[4,13,22,33,43,50,54,66,72,79,84,128,135,152,155,159,166,169,175,181,188],"controlled":[5],"release":[6,171],"and":[7,27,56,78,124],"of":[9,24,45,58,69,81,86,154,168,190],"therapeutic":[10],"drugs":[11,119],"inside":[12],"human":[14],"body,":[15],"is":[16,132,138,148],"a":[17,38,98,108,113],"promising":[18],"approach":[19],"to":[20,32,52,92,140,150,172],"increase":[21],"efficacy":[23],"administration":[26],"reduce":[28],"harmful":[29],"side":[30],"effects":[31],"body.":[34],"CDD":[35,59,70,88,115,193],"has":[36],"been":[37],"major":[39],"research":[40,103],"focus":[41],"in":[42,117,174],"field":[44],"molecular":[46],"communications":[47],"(MC)":[48],"with":[49,61],"goal":[51],"aid":[53],"design":[55,189],"optimization":[57],"systems":[60],"communication":[62],"theoretical":[63],"analysis.":[64],"However,":[65],"existing":[67],"studies":[68],"under":[71],"MC":[73,82],"framework":[74],"are":[75,120],"purely":[76],"theoretical,":[77],"potential":[80],"for":[83,112,187],"development":[85],"practical":[87],"applications":[89],"remains":[90],"yet":[91],"be":[93,185],"shown.":[94],"This":[95],"paper":[96],"presents":[97],"step":[99],"towards":[100,127],"filling":[101],"this":[102,179],"gap.":[104],"Specifically,":[105],"we":[106],"present":[107],"novel":[109],"MC-based":[110],"model":[111,137,183],"specific":[114],"system":[116],"which":[118],"embedded":[121],"into":[122],"microparticles":[123],"released":[125],"gradually":[126],"target":[129],"site.":[130],"It":[131],"demonstrated":[133],"that":[134],"proposed":[136,182],"able":[139],"faithfully":[141],"reproduce":[142],"experimental":[143],"data.":[144],"Furthermore,":[145],"statistical":[146],"analysis":[147],"conducted":[149],"explore":[151],"impact":[153],"microparticle":[156,176],"size":[157],"on":[158],"release.":[161],"The":[162],"presented":[163],"results":[164],"reveal":[165],"sensitivity":[167],"changes":[173],"size.":[177],"In":[178],"way,":[180],"can":[184],"used":[186],"future":[191],"microparticle-based":[192],"systems.":[194]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2025-10-10T00:00:00"}